New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

The American Cancer Society recently predicted there will be around 155,000 new cases of colorectal cancer and 52,900 deaths this year ... is responsible for 3% to 5% of colon cancers.

A recent study revealed that bevacizumab (Avastin) provides survival benefits in patients with colorectal cancer (CRC) for ...

Pfizer's Phase 3 BREAKWATER trial showed Braftovi combo significantly improved PFS and OS in colorectal cancer with BRAF V600E ... improvement in overall survival (OS), a key secondary endpoint ...

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

A study revealed that probiotics combined with chemotherapy and immune checkpoint inhibitors improve survival, gut health, ...